Core Viewpoint - The Chinese Academy of Traditional Chinese Medicine has announced multiple government procurement intentions for laboratory instruments, with a total budget of 129 million yuan, covering 21 types of equipment [1][2]. Procurement Overview - The procurement includes various advanced laboratory instruments such as: - Biological safety homogenizers - Biological safety vertical steam sterilizers - Fully automatic tissue dissociators - Biological safety centrifuges - High spectral imaging systems - Multi-functional enzyme labelers - Automated micro-liquid handling workstations - Rapid protein chromatography systems - Ultra-high performance liquid chromatography systems (including electrochemical detectors) - Pure water and ultra-pure water integrated machines - Mouse gait analysis systems - Medical ultra-low temperature storage boxes - High-resolution liquid chromatography-mass spectrometry systems - The expected procurement period is from May to November 2025 [2][3]. Specific Instrument Details - **Rapid Protein Chromatography System**: A high-efficiency technology for separating and purifying biomolecules, featuring wide flow rate control (0.01 - 150 ml/min) and high recovery rates, applicable in biopharmaceuticals and industrial preparation [3]. - **Biological Safety Homogenizer**: Designed for processing biological samples with a fully enclosed sterile operation to prevent contamination, used in microbiological testing and medical research [4]. - **Fully Automatic Tissue Dissociator**: Utilizes mechanical shearing and enzymatic digestion to efficiently dissociate tissues into high-activity single-cell suspensions, applicable in medical research and pathology [5]. Additional Procurement Information - The procurement also includes a variety of other instruments aimed at enhancing research capabilities in traditional Chinese medicine, such as: - High-resolution imaging systems - Automated sample processing platforms - Advanced analytical instruments for drug research and development [6][8][9].

Core Insights - The article discusses the recent announcement by the China Academy of Chinese Medical Sciences regarding the procurement of 20 types of medical instruments, with a total budget of 304 million yuan [2][3]. Procurement Overview - The procurement includes various advanced medical instruments such as: - Fast Protein Liquid Chromatography (FPLC) system - Ultra-High Performance Liquid Chromatography (UHPLC) with electrochemical detector - Pure water and ultra-pure water integrated machine - Mouse and rat gait analysis system - Medical ultra-low temperature storage box - High-resolution liquid chromatography-mass spectrometry system - The expected procurement period is from May to September 2025 [3][4]. Instrument Details - **Fast Protein Liquid Chromatography (FPLC) System**: - A core device for the efficient and automated separation and purification of biomolecules based on their physical and chemical properties [4]. - **Medical Ultra-Low Temperature Storage Box**: - Designed for the preservation of biological samples at temperatures ranging from -40°C to -196°C, crucial for maintaining sample integrity in medical research and biopharmaceuticals [5][6]. - **Live Cell Inverted Fluorescence Imaging System**: - A high-end imaging device that allows dynamic observation of live cells, integrating inverted optical structure and fluorescence imaging technology [7][8]. Detailed Procurement List - The procurement list includes various instruments aimed at enhancing research capabilities in traditional Chinese medicine and related fields, with specific budget allocations for each item [10][11][12]. - Notable items include: - High-content imaging analysis system - Mass spectrometry imaging matrix spraying instrument - High-resolution integrated spectral imaging system - Various advanced microscopy and analysis systems for biological research [10][11]. Research and Development Focus - The procurement aims to improve research conditions and capabilities in traditional Chinese medicine, with a focus on enhancing experimental platforms and methodologies [11][12]. - The investment reflects a commitment to advancing medical research and technology in the field of traditional Chinese medicine [2][3].